Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure.

× No keyword cloud information.

30 in total

1. Adenoviral SERCA1 overexpression triggers an apoptotic response in cultured neonatal but not in adult rat cardiomyocytes.

Authors: Guimei Wu; Xilin Long; José Marín-García
Journal: Mol Cell Biochem Date: 2004-12 Impact factor: 3.396

2. Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes.

Authors: Joon Lee; Mark A Stagg; Satsuki Fukushima; Gopal K R Soppa; Urszula Siedlecka; Samuel J Youssef; Ken Suzuki; Magdi H Yacoub; Cesare M N Terracciano
Journal: Am J Physiol Heart Circ Physiol Date: 2009-01-30 Impact factor: 4.733

Review 3. Gene therapies for arrhythmias in heart failure.

Authors: Fadi G Akar; Roger J Hajjar
Journal: Pflugers Arch Date: 2014-02-26 Impact factor: 3.657

Review 4. SERCA control of cell death and survival.

Authors: Elie R Chemaly; Luca Troncone; Djamel Lebeche
Journal: Cell Calcium Date: 2017-07-12 Impact factor: 6.817

Review 5. The Genetic Challenges and Opportunities in Advanced Heart Failure.

Authors: Fady Hannah-Shmouni; Sara B Seidelmann; Sandra Sirrs; Arya Mani; Daniel Jacoby
Journal: Can J Cardiol Date: 2015-08-21 Impact factor: 5.223

6. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Authors: Mariell Jessup; Barry Greenberg; Donna Mancini; Thomas Cappola; Daniel F Pauly; Brian Jaski; Alex Yaroshinsky; Krisztina M Zsebo; Howard Dittrich; Roger J Hajjar
Journal: Circulation Date: 2011-06-27 Impact factor: 29.690

7. Enhanced basal contractility but reduced excitation-contraction coupling efficiency and beta-adrenergic reserve of hearts with increased Cav1.2 activity.

Authors: Mingxin Tang; Xiaoying Zhang; Yingxin Li; Yinzheng Guan; Xiaojie Ai; Christopher Szeto; Hiroyuki Nakayama; Hongyu Zhang; Shuping Ge; Jeffery D Molkentin; Steven R Houser; Xiongwen Chen
Journal: Am J Physiol Heart Circ Physiol Date: 2010-06-11 Impact factor: 4.733

8. Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.

Authors: Emily M Schulz; Tanganyika Wilder; Shamim A K Chowdhury; Hajer N Sheikh; Beata M Wolska; R John Solaro; David F Wieczorek
Journal: J Biol Chem Date: 2013-08-19 Impact factor: 5.157

9. Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality.

Authors: Nicole Brüchert; Nirmala Mavila; Peter Boknik; Hideo A Baba; Larissa Fabritz; Ulrich Gergs; Uwe Kirchhefer; Paulus Kirchhof; Marek Matus; Wilhelm Schmitz; Anna A DePaoli-Roach; Joachim Neumann
Journal: Am J Physiol Heart Circ Physiol Date: 2008-08-08 Impact factor: 4.733

10. Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.

Authors: Ioannis Karakikes; Maengjo Kim; Lahouaria Hadri; Susumu Sakata; Yezhou Sun; Weijia Zhang; Elie R Chemaly; Roger J Hajjar; Djamel Lebeche
Journal: PLoS One Date: 2009-07-31 Impact factor: 3.240